Skip to contentSkip to filters

We use cookies for analytics.

Targeting Dementia by Tackling Synaptic Tau

Patrik Verstreken

VIB-KU Leuven Center for Neuroscience, Belgium

Abstract

Synaptic dysfunction is an early pathological feature of Tau-associated neurodegenerative diseases, including Alzheimer's disease. Targeting early synaptic dysfunction may help prevent cognitive decline and disease progression, but the mechanisms underlying Tau-associated synaptic defects remain unclear. In patients and animal models of Tau-related disease, Tau becomes mislocalized to pre- and postsynaptic compartments, and recent work shows that presynaptic Tau contributes to synaptic defects. The lecture highlights research showing that disrupting this synaptic function of Tau can prevent Tau-induced synaptic loss and cognitive decline in animal models, and discusses future studies of how the same process may operate under normal physiological conditions to sculpt and protect the brain. The work identifies new presynaptic roles for Tau and points to a potential therapeutic opportunity for addressing early synaptic dysfunction and cognitive decline in neurodegenerative disease.

Topics